title: Effects of the 5-HT2A Antagonist Sarpogrelate on Walking Ability in Patients with Intermittent Claudication as Measured Using the Walking Impairment Questionnaire.
abstract: BACKGROUND
  The Walking Impairment Questionnaire (WIQ) measures walking ability in daily life in patients with peripheral arterial disease causing intermittent claudication. We investigated the efficacy of sarpogrelate, a 5-HT2A receptor antagonist, in improving walking ability, as measured using new Japanese version of the WIQ.
  
  
  METHODS
  A nationwide multicenter study was conducted at 80 institutions in Japan involving 586 patients with stable symptoms of intermittent claudication. Patients received open-label sarpogrelate 300 mg/day. A total of 419 patients were evaluated in the full analysis set (FAS) following the intention to treat principle, and 354 patients were evaluated in the per-protocol set (PPS). The FAS data are emphasized here.
  
  
  RESULTS
  The mean follow-up was 27.7 ± 10.1 weeks. Each subscale of the WIQ score showed improvement after sarpogrelate treatment (p < 0.0001), and the resting ankle-brachial index increased significantly (p < 0.0001). The incidence of adverse reactions of the entire series of 559 patients was 4.83% (27 patients), but there were no clinically significant safety concerns.
  
  
  CONCLUSIONS
  We have for the first time demonstrated that sarpogrelate may improve walking ability in daily life in Japanese patients with intermittent claudication. The drug had a good safety profile.
authors.affiliation: Matsuo Cardiovascular Clinic, Osaka, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuo
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shigematsu
keywords: intermittent claudication; peripheral arterial disease; sarpogrelate; walking impairment questionnaire
references.citation: J Thromb Haemost. 2006 Jan;4(1):247-55
references.pmid: 16409475
references.citation: Vasc Med. 1996;1(1):3-7
references.pmid: 9546911
references.citation: J Vasc Surg. 2002 Jul;36(1):94-9
references.pmid: 12096264
references.citation: J Am Coll Cardiol. 2006 Dec 19;48(12):2539-45
references.pmid: 17174195
references.citation: Int Angiol. 2002 Mar;21(1):20-7
references.pmid: 11941270
references.citation: J Neurosurg Spine. 2005 Apr;2(4):441-6
references.pmid: 15871484
references.citation: Ann Cardiol Angeiol (Paris). 2001 Apr;50(3):175-82
references.pmid: 12555510
references.citation: Thromb Haemost. 1991 Apr 8;65(4):415-20
references.pmid: 2057925
references.citation: J Vasc Surg. 1998 Dec;28(6):1072-81
references.pmid: 9845659
references.citation: J Vasc Surg. 2008 Mar;47(3):550-555
references.pmid: 18207355
references.citation: Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
references.pmid: 17140820
references.citation: J Vasc Surg. 1996 Oct;24(4):503-11; discussion 511-2
references.pmid: 8911399
references.citation: Pharmacol Ther. 2004 Oct;104(1):59-81
references.pmid: 15500909
references.citation: J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296
references.pmid: 10666287
references.citation: J Vasc Surg. 1998 Feb;27(2):267-74; discussion 274-5
references.pmid: 9510281
references.citation: Eur J Clin Invest. 1988 Aug;18(4):399-404
references.pmid: 3139426
references.citation: J Vasc Surg. 2004 Jun;39(6):1186-92
references.pmid: 15192556
references.citation: Br J Surg. 1997 Oct;84(10):1419-24
references.pmid: 9361603
references.citation: Angiology. 1993 Jan;44(1):1-10
references.pmid: 8424578
references.citation: J Pharmacol Exp Ther. 1999 Sep;290(3):1475-81
references.pmid: 10454527
references.citation: J Invasive Cardiol. 2006 Jul;18(7):316-21
references.pmid: 16816437
references.citation: Int Angiol. 2001 Mar;20(1):58-65
references.pmid: 11342997
references.citation: Circulation. 1995 Aug 1;92(3):614-21
references.pmid: 7634476
references.citation: JAMA. 2001 Sep 19;286(11):1317-24
references.pmid: 11560536
references.citation: Pharmacol Rev. 1994 Jun;46(2):157-203
references.pmid: 7938165
references.citation: Vasc Med. 2006 May;11(2):75-83
references.pmid: 16886837
references.citation: J Am Coll Cardiol. 1998 Dec;32(7):1982-6
references.pmid: 9857882